BFS
Bard Financial Services Portfolio holdings
AUM
$837M
This Quarter Return
+0.43%
1 Year Return
+16.73%
3 Year Return
+64.11%
5 Year Return
–
10 Year Return
–
AUM
$834M
AUM Growth
+$834M
(-1.6%)
Cap. Flow
-$556K
Cap. Flow
% of AUM
-0.07%
Top 10 Holdings %
Top 10 Hldgs %
40.04%
Holding
216
New
4
Increased
37
Reduced
64
Closed
7
Top Buys
| 1 |
Tesla
TSLA
|
$2.56M |
| 2 |
Apple
AAPL
|
$950K |
| 3 |
DNP Select Income Fund
DNP
|
$763K |
| 4 |
GSK
GSK
|
$742K |
| 5 |
Newmont
NEM
|
$651K |
Top Sells
| 1 |
Microsoft
MSFT
|
$1.01M |
| 2 |
WPP
WPP
|
$1,000K |
| 3 |
EQT Corp
EQT
|
$895K |
| 4 |
Wells Fargo
WFC
|
$880K |
| 5 |
CVS Health
CVS
|
$705K |
Sector Composition
| 1 | Technology | 30.63% |
| 2 | Consumer Staples | 13.25% |
| 3 | Financials | 11.8% |
| 4 | Healthcare | 11.79% |
| 5 | Consumer Discretionary | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Oracle
ORCL
$628B
| $4.54M | 0.54% |
27,250
| – | – |
|
52
Shell
SHEL
$211B
| $4.11M | 0.49% |
65,600
-1,675
| -2% | -$105K |
|
53
Blackrock
BLK
$170B
| $4.05M | 0.49% |
3,950
-60
| -1% | -$61.5K |
|
54
BioLife Solutions
BLFS
$1.2B
| $3.98M | 0.48% |
153,475
| – | – |
|
55
British American Tobacco
BTI
$120B
| $3.91M | 0.47% |
107,635
+13,426
| +14% | +$488K |
|
56
Honeywell
HON
$136B
| $3.82M | 0.46% |
16,894
-100
| -0.6% | -$22.6K |
|
57
Broadcom
AVGO
$1.42T
| $3.74M | 0.45% |
16,150
-550
| -3% | -$128K |
|
58
Qualcomm
QCOM
$170B
| $3.67M | 0.44% |
23,875
| – | – |
|
59
Realty Income
O
$53B
| $3.57M | 0.43% |
66,805
-765
| -1% | -$40.9K |
|
60
Visa
V
$681B
| $3.44M | 0.41% |
10,885
-75
| -0.7% | -$23.7K |
|
61
CarMax
KMX
$9.04B
| $3.25M | 0.39% |
39,710
+660
| +2% | +$54K |
|
|
62
Newmont
NEM
$82.8B
| $3.21M | 0.38% |
86,180
+17,480
| +25% | +$651K |
|
63
General Dynamics
GD
$86.8B
| $3.17M | 0.38% |
12,045
| – | – |
|
64
US Bancorp
USB
$75.5B
| $2.94M | 0.35% |
61,409
-1,500
| -2% | -$71.7K |
|
65
RTX Corp
RTX
$212B
| $2.86M | 0.34% |
24,755
| – | – |
|
66
Palo Alto Networks
PANW
$128B
| $2.86M | 0.34% |
15,710
+7,930
| +102% | +$27.3K |
|
67
Gilead Sciences
GILD
$140B
| $2.78M | 0.33% |
30,095
| – | – |
|
68
Air Products & Chemicals
APD
$64.8B
| $2.76M | 0.33% |
9,500
+50
| +0.5% | +$14.5K |
|
69
Infosys
INFY
$69B
| $2.73M | 0.33% |
124,340
| – | – |
|
70
IBM
IBM
$227B
| $2.72M | 0.33% |
12,390
| – | – |
|
|
71
GSK
GSK
$79.3B
| $2.67M | 0.32% |
79,095
+21,950
| +38% | +$742K |
|
72
Medtronic
MDT
$118B
| $2.46M | 0.29% |
30,755
-8,000
| -21% | -$639K |
|
73
GE Aerospace
GE
$293B
| $2.45M | 0.29% |
14,660
-135
| -0.9% | -$22.5K |
|
74
Lam Research
LRCX
$124B
| $2.44M | 0.29% |
33,750
+30,375
| +900% | – |
|
75
Victory Capital Holdings
VCTR
$4.71B
| $2.35M | 0.28% |
35,960
| – | – |
|